TARS2 and cholelithiasis: This study, using the SMR and HEIDI testing methods, investigated the association of genetically predicted mitochondrial-related gene methylation, gene expression, and cholelithiasis, identifying 4 potential drug targets for cholelithiasis: TARS2, LIAS, HEBP1, and PNKD.